Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference
Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference
MINNEAPOLIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024.
明尼阿波利斯，2024年11月06日(GLOBE NEWSWIRE) -- inspire medical systems, Inc. (紐交所: INSP) (Inspire)，一家專注於開發和商業化創新、微創解決方案，用於治療阻塞性睡眠呼吸暫停症患者的醫療科技公司，今天宣佈其管理團隊將於2024年11月20日(週三)在Jefferies倫敦醫療保健大會上發表演講。
Inspire is scheduled to present at 11:00 a.m. Eastern Time. The presentation will be accessible via a live webcast here.
Inspire計劃在美國東部時間上午11:00進行演講。演示將通過此處的現場網絡廣播進行訪問。
Webcast replays of the presentations will be available for two weeks following the presentations in the Event Archive section of Inspire's Investor website at .
演示的網絡廣播重播將在演示結束後的兩週內通過Inspire投資者網站的活動存檔部分提供。
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology of its kind that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
關於inspire 醫療系統
Inspire是一家專注於開發和商業化創新、微創解決方案，用於治療阻塞性睡眠呼吸暫停症患者的醫療科技公司。Inspire的專有Inspire療法是首款並且唯一一款獲得FDA、EU MDR和PDMA批准的神經刺激技術，爲中重度阻塞性睡眠呼吸暫停提供安全有效的治療方案。
For additional information about Inspire, please visit .
更多關於inspire的信息，請訪問。
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
投資者和媒體聯繫人
Ezgi Yagci
投資者關係副總裁
ezgiyagci@inspiresleep.com
617-549-2443
譯文內容由第三人軟體翻譯。
